Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:LQDA News 2 January 2026 - 11 January 2026

Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week

Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week

Liquidia shares rose 12.9% to $35.86 Friday after the company reported preliminary 2025 YUTREPIA sales of $148.3 million, with $90.1 million in Q4. The company ended 2025 with $190.7 million in cash and over $30 million in positive Q4 cash flow. CEO Roger Jeffs will present at the J.P. Morgan Healthcare Conference on Jan. 14. Audited results are expected in February.
11 January 2026
···
Liquidia stock slides after Needham swaps LQDA off its 2026 Conviction List

Liquidia stock slides after Needham swaps LQDA off its 2026 Conviction List

New York, Jan 6, 2026, 15:31 EST — Regular session Shares of Liquidia Corp (LQDA) fell 6.2% to $30.17 in afternoon trading on Tuesday after Needham removed the stock from its 2026 “Conviction List,” a report said. The shares hit a session low of $29.47, down from Monday’s close of $32.15. The decline stood out against a firmer biotech backdrop. The SPDR S&P Biotech ETF was up about 1.1% and the iShares Nasdaq Biotechnology ETF gained about 2.0%. For Liquidia, sentiment often tracks expectations for Yutrepia, its inhaled treprostinil powder used to treat pulmonary arterial hypertension (PAH), a form of
6 January 2026
···
Liquidia stock heads into Monday after 9% slide and spike in bearish put options

Liquidia stock heads into Monday after 9% slide and spike in bearish put options

NEW YORK, Jan 4, 2026, 10:59 ET — Market closed Liquidia Corporation shares slid in the last U.S. session as options traders piled into downside protection, putting the biotech stock on watch ahead of Monday’s reopen. The move matters because the options market often telegraphs how investors are positioning for near-term swings, especially in event-driven healthcare names where single headlines can shift the outlook. Put options — contracts that give the holder the right to sell shares at a set price — can be used to hedge existing stock positions or to bet on a decline. Heavy put demand can
4 January 2026
·
Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

NEW YORK, January 3, 2026, 20:03 ET — Market closed Liquidia Corp shares ended sharply lower on Friday, retreating about 9% to $31.40 and giving back ground after trading near a fresh 52-week high earlier in the session. The drop matters because it came on the first U.S. trading day of 2026, a period when investors often reset risk and rebalance exposure in small- and mid-cap healthcare names. Liquidia’s move was far larger than the broader biotech tape. Derivatives positioning added to the focus. Options activity flagged unusually heavy demand for bearish protection tied to $30, a strike that sits
4 January 2026
·
Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Liquidia Corp shares slid about 8% in afternoon trade on Friday, giving back earlier gains and underperforming the broader biotech group. The stock was down $2.79 at $31.70, after trading between $30.76 and $34.97. Volume topped 1.88 million shares. The move matters because Liquidia has become a high-volatility bet on sales of Yutrepia, its inhaled treprostinil therapy for pulmonary hypertension. On its Nov. 3 earnings call, the company said third-quarter net product sales were $51.7 million, and chief operating officer and CFO Michael Kaseta told investors, “We expect this positive trend to extend into 2026.” Investing Liquidia entered 2026 after
2 January 2026
···

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop